Podcasts

Not So Different: What the Generics Industry Can Tell Us About the Future of Biosimilars

July 18th 2021

On this week’s episode of Not So Different, we spoke with David Senior, senior vice president of Market Economics at AmerisourceBergen, about the development of the generics market and how this could be instructive in understanding how biosimilars sales may develop.

Not So Different: Axinn Patent Litigator Discusses Implications of ACA Ruling

July 4th 2021

Podcast

The Supreme Court’s ruling in the Affordable Care Act (ACA) case appears to have saved the biosimilars approval pathway, but do the plaintiffs have other avenues by which to bring another challenge?

Not So Different: How Henlius is Making Its Mark on the Global Biosimilar Industry

June 20th 2021

Podcast

Ping Cao, vice president of Business Development for Shanghai Henlius Biotech, discussed the company's current biosimilar development plans and the process for getting regulatory approval for biosimilars in China.

Not So Different: How Pharmacists Can Help Boost Biosimilar Uptake

May 23rd 2021

Podcast

Sonia T. Oskouei, PharmD, BCMAS, DPLA, from Cardinal Health, highlights ways pharmacists can be proactive in the effort to improve biosimilar uptake in the United States.

Not So Different: The Fight to Align Payer Preferences With Community Oncology

May 9th 2021

Podcast

This is the third and final part of our series on National Comprehensive Cancer Network/Pfizer efforts to investigate issues of importance to biosimilar stakeholders.

Not So Different: What’s Stopping Physicians From Prescribing Biosimilars?

April 25th 2021

Podcast

This is the second of a 3-part series on National Comprehensive Cancer Network/Pfizer efforts to investigate issues of importance to biosimilar stakeholders.

Not So Different: How to Improve Perception Hurdles to Biosimilar Adoption

April 11th 2021

Podcast

This is part 1 of a series on National Comprehensive Cancer Network/Pfizer efforts to investigate issues of importance to biosimilar stakeholders.

Not So Different: Has Brexit Hindered Biosimilar Development?

April 4th 2021

Podcast

Maria Manley, LLM, a life sciences expert, talks about how the United Kingdom’s exit from the European Union has changed the regulatory landscape for biologics.

Dr Juliette Petit: How Nurses Can Prevent Nocebo Effect in Biosimilar Switching

March 28th 2021

Podcast

Juliette Petit, MD, a French rheumatologist, talks about her recent study showing that nurses can help curb patient fears and prevent a possible nocebo effect when switching them to a biosimilar.

Not So Different: Minnesota Legislator Discusses Bill to Broaden Biosimilar Coverage

March 14th 2021

Podcast

State Representative Jennifer Schultz (D, Duluth) explains how her bill requiring payers to cover all approved biosimilars and reference products would save money and improve access.